REMOTION: a Trial to Investigate the Feasibility and Potential Effectiveness of a Blended, Transdiagnostic Intervention for Symptom Reduction and Improvement of Emotion Regulation in an Outpatient Psychotherapeutic Setting (REMOTION)
REMOTION: a Randomized Controlled Pilot Trial to Investigate the Feasibility and Potential Effectiveness of a Blended, Transdiagnostic Intervention for Symptom Reduction and Improvement of Emotion Regulation in an Outpatient Psychotherapeutic Setting
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bern, Switzerland, 3012
- Psychotherapeutische Praxisstelle, Universität Bern
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 18 years or older
- In psychotherapeutic treatment at the outpatient clinic of the Department of Clinical Psychology at the University of Bern
- Mental disorder present
- Internet access available
- Written informed consent
Exclusion Criteria:
- Current participation in another intervention, outside of the treatment at the outpatient clinic, that is geared specifically at emotion regulation
- Current or history of psychotic disorders or bipolar disorder
- Acute suicidality
- Insufficient mastery of German language
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: REMOTION + TAU
Participants in the REMOTION group receive REMOTION in addition to psychotherapy at the outpatient clinic of the Department of Clinical Psychology and Psychotherapy at the University of Bern.
|
REMOTION is an internet-based intervention aimed at transdiagnostically reducing symptom severity and improving emotion regulation of psychotherapy patients.
The structure of REMOTION is based on the idea of an extended process model of emotion regulation as postulated by J.J. Gross (2015).
The program includes the following modules: introduction, psychoeducation, identification, selection, implementation and monitoring/modification.
A variety of elements based on different psychotherapy approaches (Cognitive Behavioral Therapy, Emotion Focused Therapy, Dialectical Behavior Therapy etc.) are integrated in the program.
Participants should work through one module per week.
REMOTION is administered as an add-on to treatment as usual (TAU), which is psychotherapy at the outpatient clinic of the Department of Clinical Psychology and Psychotherapy at the University of Bern.
Treatment as usual (TAU) refers to psychotherapy at the outpatient clinic of the Department of Clinical Psychology and Psychotherapy at the University of Bern.
Psychotherapy at the outpatient clinic is based on Psychological Therapy (Grawe, 1998) principles, which are largely rooted in academic psychology and which mainly draw on interventions from Cognitive Behavior Therapy.
Individual case conceptualization are key in Psychological Therapy, along with general therapeutic factors and a focus on the therapeutic relationship.
|
|
Active Comparator: TAU
Participants in TAU receive psychotherapy at the outpatient clinic of the Department of Clinical Psychology and Psychotherapy at the University of Bern.
|
Treatment as usual (TAU) refers to psychotherapy at the outpatient clinic of the Department of Clinical Psychology and Psychotherapy at the University of Bern.
Psychotherapy at the outpatient clinic is based on Psychological Therapy (Grawe, 1998) principles, which are largely rooted in academic psychology and which mainly draw on interventions from Cognitive Behavior Therapy.
Individual case conceptualization are key in Psychological Therapy, along with general therapeutic factors and a focus on the therapeutic relationship.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
General symptom severity
Time Frame: baseline
|
Assessed with Brief Symptom Inventory (Franke, 2000, German version)
|
baseline
|
|
General symptom severity
Time Frame: 6 weeks
|
Assessed with Brief Symptom Inventory (Franke, 2000, German version)
|
6 weeks
|
|
General symptom severity
Time Frame: 12 weeks
|
Assessed with Brief Symptom Inventory (Franke, 2000, German version)
|
12 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difficulties in emotion regulation
Time Frame: baseline, 6 weeks,12 weeks
|
Assessed with Difficulties in Emotion Regulation Scale (DERS, Gratz & Roemer, 2004, German version by Ehring et al., 2008).
|
baseline, 6 weeks,12 weeks
|
|
Emotion competencies questionnaire
Time Frame: baseline, 6 weeks, 12 weeks
|
Assessed with Emotion Competencies Questionnaire (SEK-27, Berking & Znoj, 2008)
|
baseline, 6 weeks, 12 weeks
|
|
Depressive Symptoms
Time Frame: baseline, 6 weeks, 12 weeks
|
Assessed with Patient Health Questionnaire-9 (PHQ-9, German version by Löwe & Spitzer, 2002).
|
baseline, 6 weeks, 12 weeks
|
|
Anxiety symptoms
Time Frame: baseline, 6 weeks, 12 weeks
|
Assessed with Generalized Anxiety Disorder Scale-7 (GAD-7, German version by Löwe et al., 2008)
|
baseline, 6 weeks, 12 weeks
|
|
Well-Being
Time Frame: baseline, 6 weeks, 12 weeks
|
Assessed with the World Health Organisation-Five Well-Being Index (German version, Brähler, et al., 2007).
|
baseline, 6 weeks, 12 weeks
|
|
Health related quality of life
Time Frame: baseline, 6 weeks, 12 weeks
|
Assessed with the Short Form Health Survey (SF-12, German version by Gandek et al., 1998)
|
baseline, 6 weeks, 12 weeks
|
|
Feasibility parameter: number of participants taking part in the study
Time Frame: at randomization
|
at randomization
|
|
|
Feasibility parameter: adherence
Time Frame: 6 weeks,12 weeks (REMOTION group only)
|
Adherence assessed by amount of modules completed
|
6 weeks,12 weeks (REMOTION group only)
|
|
Feasibility parameter: adherence
Time Frame: 6 weeks,12 weeks (REMOTION group only)
|
Adherence assessed by amount of pages visited in REMOTION
|
6 weeks,12 weeks (REMOTION group only)
|
|
Feasibility parameter: adherence
Time Frame: 6 weeks, 12 weeks (REMOTION group only)
|
Adherence assessed by amount of exercises completed in REMOTION
|
6 weeks, 12 weeks (REMOTION group only)
|
|
Feasibility parameter: program usability
Time Frame: 6 weeks, 12 weeks (REMOTION group only)
|
Assessed with the System Usability Scale (SUS, Brooke, 1996)
|
6 weeks, 12 weeks (REMOTION group only)
|
|
Feasibility parameter: user experience
Time Frame: 6 weeks, 12 weeks (REMOTION group only)
|
Assessed with the meCUE questionnaire (Minge & Riedel, 2013)
|
6 weeks, 12 weeks (REMOTION group only)
|
|
Feasibility parameter: attitude toward psychological online interventions
Time Frame: baseline, 6 weeks, 12 weeks
|
Attitudes will be assessed with the Attitude toward Psychological Online Interventions Questionnaire (APOI, German version by Schröder, 2015).
|
baseline, 6 weeks, 12 weeks
|
|
Feasibility parameter: satisfaction with the intervention
Time Frame: 6 weeks, 12 weeks (REMOTION group only)
|
Assessed with the Client Satisfaction Questionnaire (CSQ-8, German version by Schmidt, 1989, and adapted for internet interventions).
|
6 weeks, 12 weeks (REMOTION group only)
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Therapeutic alliance
Time Frame: 6 weeks, twelve weeks
|
Alliance will be assessed with the Working Alliance Inventory (WAI-SR, German version by Wilmers et al., 2008)
|
6 weeks, twelve weeks
|
|
Self Compassion
Time Frame: baseline, six weeks, twelve weeks
|
Assessed with the Self Compassion Scale (German version by Hupfeld & Ruffieux, 2011)
|
baseline, six weeks, twelve weeks
|
|
Negative effects of REMOTION
Time Frame: six weeks, 12 weeks (REMOTION group only)
|
Assessed with an adapted version of the Inventory to Assess Negative Effects of Psychotherapy (INEP; Ladwig et al., 2014)
|
six weeks, 12 weeks (REMOTION group only)
|
|
Therapist variables
Time Frame: baseline, 6 weeks, 12 weeks
|
Assessed with items created for the study (demographics, use of emotion regulation interventions in therapy, use of online interventions in therapy)
|
baseline, 6 weeks, 12 weeks
|
|
Therapist variables specific to REMOTION
Time Frame: 6 weeks, 12 weeks (REMOTION group only)
|
Assessed with items created for the study (for example perceived effect of REMOTION etc.)
|
6 weeks, 12 weeks (REMOTION group only)
|
|
Patient emotion regulation difficulties as rated by the therapist
Time Frame: baseline, 6 weeks,12 weeks
|
Assessed with the DERS-t (modified version of the German version by Ehring et al., 2008)
|
baseline, 6 weeks,12 weeks
|
|
Patient emotion regulation competencies as rated by the therapist
Time Frame: baseline, 6 weeks, 12 weeks
|
Assessed with the SEK-27-t (modified version of the German version by Bering & Znoj, 2008)
|
baseline, 6 weeks, 12 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Thomas Berger, Prof. Dr., Department of Clinical Psychology and Psychotherapy, Institute of Psychology, University of Bern
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2019-01929
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.